Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Likeability of OROS vs SODAS Methylphenidate in Healthy Adults
NCT00302354Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Pharmacokinetics (d- and l-ritalinic acid and methylphenidate levels) at 12 hours. Started Dec 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00302354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302354.